RELMADA THERAPEUTICS, INC. Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount
RELMADA THERAPEUTICS, INC. (RLMD) had Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount of $493.45 thousand as of 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Leases
us-gaap:LessorOperatingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount · last filed 2024-03-19
- 2023-12-31: Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount $493.45K.
| Period end | Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount |
|---|---|
| 2023-12-31 | $493.45K 10-K · filed 2024-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |